Key result
Acute kidney injury induces cardiac dysfunction through a complex interplay of hemodynamic mechanisms (SNS and RAAS activation) and non-hemodynamic mechanisms including inflammation, oxidative stress, and mitochondrial fission.
Why the study?
Cardiorenal syndrome type 3 occurs commonly in severe acute kidney injury and causes worse outcomes, motivating a review of its pathophysiological mechanisms, management approaches, targeted therapeutics, and diagnostic challenges.
This review elucidates the bidirectional pathways—particularly inflammation, oxidative stress, and mitochondrial dynamics—that mediate acute kidney injury-induced cardiac dysfunction, providing a framework for future targeted therapeutics.
Communication between the heart and kidney occurs through various bidirectional pathways. The heart maintains continuous blood flow through the kidney while the kidney regulates blood volume thereby allowing the heart to pump effectively. Cardiorenal syndrome (CRS) is a pathologic condition in which acute or chronic dysfunction of the heart or kidney induces acute or chronic dysfunction of the other organ. CRS type 3 (CRS-3) is defined as acute kidney injury (AKI)-mediated cardiac dysfunction. AKI is common among critically ill patients and correlates with increased mortality and morbidity. Acute cardiac dysfunction has been observed in over 50% of patients with severe AKI and results in poorer clinical outcomes than heart or renal dysfunction alone. In this review, we describe the pathophysiological mechanisms responsible for AKI-induced cardiac dysfunction. Additionally, we discuss current approaches in the management of patients with CRS-3 and the development of targeted therapeutics. Finally, we summarize current challenges in diagnosing mild cardiac dysfunction following AKI and in understanding CRS-3 etiology.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) conducted a review in Cardiorenal syndrome type 3 (CRS-3). Acute kidney injury was evaluated. Acute kidney injury induces cardiac dysfunction through a complex interplay of hemodynamic mechanisms (SNS and RAAS activation) and non-hemodynamic mechanisms including inflammation, oxidative stress, and mitochondrial fission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: